Search Results - "Vaios, Vasilios"

Refine Results
  1. 1

    Therapeutic Advances in Diabetic Kidney Disease by Georgianos, Panagiotis I, Vaios, Vasilios, Eleftheriadis, Theodoros, Papachristou, Evangelos, Liakopoulos, Vassilios

    “…Although sodium glucose co-transporter type 2 (SGLT-2) inhibitors were initially introduced as glucose-lowering medications, it was later discovered that…”
    Get full text
    Journal Article
  2. 2

    Vitamin K Supplementation for Prevention of Vascular Calcification in Chronic Kidney Disease Patients: Are We There Yet? by Roumeliotis, Stefanos, Duni, Anila, Vaios, Vasilios, Kitsos, Athanasios, Liakopoulos, Vassilios, Dounousi, Evangelia

    Published in Nutrients (22-02-2022)
    “…Chronic Kidney Disease (CKD) patients are at high risk of presenting with arterial calcification or stiffness, which confers increased cardiovascular mortality…”
    Get full text
    Journal Article
  3. 3

    A comparative analysis of ambulatory BP profile and arterial stiffness between CAPD and APD by Vaios, Vasilios, Georgianos, Panagiotis I., Vareta, Georgia, Dounousi, Evangelia, Eleftheriadis, Theodoros, Papagianni, Aikaterini, Zebekakis, Pantelis E., Liakopoulos, Vassilios

    Published in Journal of human hypertension (01-03-2022)
    “…Prior studies have associated automated peritoneal dialysis (APD) with less effective volume and blood pressure (BP) control as compared with continuous…”
    Get full text
    Journal Article
  4. 4

    Feeding during Dialysis Increases Intradialytic Blood Pressure Variability and Reduces Dialysis Adequacy by Fotiadou, Elena, Georgianos, Panagiotis I, Vaios, Vasilios, Sgouropoulou, Vasiliki, Divanis, Dimitrios, Karligkiotis, Apostolos, Leivaditis, Konstantinos, Chourdakis, Michail, Zebekakis, Pantelis E, Liakopoulos, Vassilios

    Published in Nutrients (24-03-2022)
    “…Whether hemodialysis patients should be allowed or even encouraged to eat during dialysis remains a controversial topic. This cross-over study aimed to…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence by Georgianos, Panagiotis I, Vaios, Vasilios, Eleftheriadis, Theodoros, Zebekakis, Pantelis, Liakopoulos, Vassilios

    Published in Current vascular pharmacology (01-01-2017)
    “…Add-on therapy with the Mineralocorticoid-Receptor-Antagonists (MRAs) spironolactone and eplerenone was shown to enhance the cardioprotective action of…”
    Get more information
    Journal Article
  8. 8

    10-year-long survival in a PD patient with severe calcifying encapsulating peritoneal sclerosis treated with tamoxifen: a case-report by Liakopoulos, Vassilios, Georgianos, Panagiotis I, Vaios, Vasilios, Roumeliotis, Stefanos, Karligkiotis, Apostolos, Zebekakis, Pantelis E

    Published in BMC nephrology (31-03-2020)
    “…Encapsulating-peritoneal-sclerosis (EPS) is a rare, but serious and life-threatening complication of peritoneal dialysis (PD). Treatment of EPS consists of…”
    Get full text
    Journal Article
  9. 9

    Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology by Georgianos, Panagiotis I, Vaios, Vasilios, Sgouropoulou, Vasiliki, Eleftheriadis, Theodoros, Tsalikakis, Dimitrios G, Liakopoulos, Vassilios

    Published in Diagnostics (Basel) (26-11-2022)
    “…Whereas hypertension is an established cardiovascular risk factor in the general population, the contribution of increased blood pressure (BP) to the huge…”
    Get full text
    Journal Article
  10. 10

    Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report by Liakopoulos, Vassilios, Georgianos, Panagiotis I, Demirtzi, Paraskevi, Vaios, Vasilios, Kalathas, Theofanis, Zebekakis, Pantelis E

    Published in BMC nephrology (25-10-2018)
    “…Icodextrin is a starch-derived, water soluble glucose polymer, which is used as an alternative to glucose in order to enhance dialytic fluid removal in…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab by Zebekakis, Pantelis, Sioulis, Athanasios, Koletsa, Triantafyllia, Karayannopoulou, Georgia, Leontaridou, Eleni, Vaios, Vasilios, Georgianos, Panagiotis I., Balaskas, Elias V.

    Published in Case reports in nephrology (2019)
    “…Immune-checkpoint-inhibitors (ICPIs) represent a novel class of immunotherapy against several malignancies. These agents are associated with several…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Slowing the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes Using Four Pillars of Therapy: The Time to Act is Now by Georgianos, Panagiotis I, Vaios, Vasilios, Koufakis, Theocharis, Liakopoulos, Vassilios

    Published in Drugs (New York, N.Y.) (11-09-2024)
    “…Chronic kidney disease (CKD) is the most common co-morbidity in patients with type 2 diabetes (T2D) and its presence substantially amplifies the risk for…”
    Get full text
    Journal Article
  15. 15

    Assessment and Management of Hypertension among Patients on Peritoneal Dialysis by Vaios, Vasilios, Georgianos, Panagiotis I, Liakopoulos, Vassilios, Agarwal, Rajiv

    “…Approximately 7%-10% of patients with ESKD worldwide undergo peritoneal dialysis (PD) as kidney replacement therapy. The continuous nature of this dialytic…”
    Get full text
    Journal Article
  16. 16

    SEX DIFFERENCES IN SHORT-TERM BP VARIABILITY AMONG PATIENTS UNDERGOING PERITONEAL DIALYSIS by Vaios, Vasilios, Georgianos, Panagiotis, Vareta, Georgia, Leptokaridou, Eirini, Kontogiorgos, Ioannis, Geropoulou, Evangelia, Zebekakis, Pantelis, Liakopoulos, Vassilios

    Published in Journal of hypertension (01-06-2023)
    “…Objective: The present study aimed to explore potential differences in short-term blood pressure (BP) variability between men and women with end-stage kidney…”
    Get full text
    Journal Article
  17. 17

    THE RENIN ANGIOTENSIN SYSTEM BLOCKADE DOES NOT SIGNIFICANTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS IN DIALYSIS PATIENTS: A META-ANALYSIS OF 5 RCTS by Georgianos, Panagiotis, Tziatzios, Georgios, Roumeliotis, Stefanos, Georgianou, Eleni, Vaios, Vasilios, Liakopoulos, Vassilios, Agarwal, Rajiv

    Published in Journal of hypertension (01-06-2023)
    “…Objective: Angiotensin-converting-enzyme-inhibitors (ACEIs) and/or angiotensin-receptor-blockers (ARBs) are recommended by guidelines as first-line therapies…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20